The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Intensity of bruising on TXA + HA half of face
Timeframe: Post-procedure day 7
Intensity of bruising on saline + HA half of face
Timeframe: Post-procedure day 7
Duration of bruising on TXA + HA half of face
Timeframe: Post-procedure day 7
Duration of bruising on saline + HA half of face
Timeframe: Post-procedure day 7